Okay, let's tackle this question about the enzyme defect in acute intermittent porphyria (AIP). First, I need to recall what AIP is. I remember that porphyrias are a group of metabolic disorders affecting heme synthesis. Each type is caused by a deficiency in a specific enzyme in the heme biosynthesis pathway.

The heme pathway has eight enzymes, and each deficiency leads to a different porphyria. For AIP, the key enzyme involved is porphobilinogen deaminase (PBGD), also known as hydroxymethylbilane synthase. This enzyme catalyzes the conversion of porphobilinogen (PBG) to hydroxymethylbilane, which is a crucial step in the pathway. If this enzyme is defective, PBG accumulates, leading to the symptoms of AIP like abdominal pain, neurological issues, and psychiatric symptoms.

Now, looking at the options provided, though they aren't listed here, the correct answer should be PBGD. The other options would likely include other enzymes from the heme pathway. For example, delta-aminolevulinic acid dehydratase (ALAD) is involved in another type of porphyria, acute hepatic porphyria. Uroporphyrinogen I synthase is deficient in congenital erythropoietic porphyria. Uroporphyrinogen III synthase is the issue in porphyria cutanea tarda. So those would be incorrect because they are associated with different types of porphyrias.

The clinical pearl here is that AIP is autosomal dominant and primarily affects the liver, leading to neurovisceral symptoms. Remembering the enzyme PBGD is key. The high-yield fact is that PBG accumulates in AIP, and the enzyme deficiency is PBGD. Also, the mnemonic "Porphyria's Porphyria's" might help, but more importantly, linking the enzyme to the symptoms and the type of porphyria is essential for exams. The correct answer is PBGD, so the letter corresponding to that enzyme in the options would be the right choice.

**Core Concept**
Acute intermittent porphyria (AIP) is a metabolic disorder caused by a deficiency in **porphobilinogen deaminase (PBGD)**, a key enzyme in heme biosynthesis. This leads to accumulation of toxic precursors like delta-aminolevulinic acid (ALA) and porphobilinogen (PBG), causing neurovisceral symptoms.

**Why the Correct Answer is Right**
PBGD catalyzes the condensation of porphobilinogen molecules to form hydroxymethylbilane, a rate-limiting step in heme production. Its deficiency results in excessive ALA and PBG accumulation, which are neurotoxic. Symptoms include abdominal pain, neuropathy, and psychiatric disturbances. Genetic testing confirms reduced PBGD activity in AIP.

**Why Each Wrong Option is Incorrect**
**Option A:** Delta-aminolevulinic acid dehydratase (ALAD) deficiency causes acute hepatic porphyria, not AIP.
**Option B:** Uroporphyrinogen I synthase deficiency leads to congenital erythropoietic porphyria.
**Option C:** Uroporphyrinogen III synthase deficiency is the

✓ Correct Answer: A. PMB deaminase